ARCHIVES

Joint NCI/FDA Program approved; ‘May Solve Our Differences’

This article is from The Cancer Letter archive.

Vol. 15 No. 48 | December 15, 1989

Download PDF Visit The Full Archive

Related Articles

ASCO President Criticizes Use Of Cooperative Agreement in Clinical Trials

May 18, 1984

Scientific Process

September 25, 1998

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

September 29, 2000

New NCI Grant Program Will Support Young Scientists In Innovative, “Risky” Research

May 27, 1977

Study Finds No Link Between Tumor Grade and Relapse Risk

February 25, 2011

NCI Barred PI Wolmark And Its Own Prevention Staff From Ad Hod Meeting.

April 20, 2007